Jessica Hagen
Dr. Ricky Bloomfield, Oura's first CMO, spoke with MobiHealthNews about his plans for the company and his vision to personalize Oura's offerings using generative AI.
The company has secured 510(k) clearance for its Apple Watch-powered seizure monitoring platform, expanding the role of wearables in epilepsy care.
The partnership will allow Wisp members to access pelvic health care and Origin patients discounts on Wisp's reproductive and sexual health offerings.
A study published in Cell reveals a paralyzed man could control a robotic arm for seven months following the implantation of an AI-enabled brain-computer interface.
The course aims to help doctors, researchers and healthcare professionals learn about generative AI and LLMs and how the technology is used in healthcare.
Luke Hansen, chief medical officer at Arcadia, provides MobiHealthNews with highlights of the event for the company and its plans for 2025.
Wysa's AI-enabled chatbot will be accessible to patients between visits with psychiatrists and behavioral health specialists.
The funds will be used to advance Insilico's drug pipeline and lab, which automates the research and development process, and refine its AI-enabled models and algorithms.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.